Erratum to: Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch (World Journal of Urology, (2012), 30, (861-867), 10.1007/s00345-011-0819-4);Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch

World Journal of Urology

Volumn 30, Issue 6, 2012, Pages 861-867

  Han, Bangmin ^a   Cui, Di ^a   Jing, Yifeng ^a   Hong, Yan ^a   Xia, Shujie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Bladder cancer; Cadherin switch; Estrogen receptor

Indexed keywords

EID: 84870381638     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1677-2     Document Type: Erratum

References (21)

1. McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163(3): 236-244. doi: 10. 1093/aje/kwj028.
2. Davis-Dao CA, Henderson KD, Sullivan-Halley J, Ma H, West D, Xiang YB, Gago-Dominguez M, Stern MC, Castelao JE, Conti DV, Pike MC, Bernstein L, Cortessis VK (2011) Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 20(6): 1156-1170. doi: 1055-9965. EPI-11-0017[pii]10. 1158/1055-9965. EPI-11-0017.
3. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106(12): 2610-2616. doi: 10. 1002/cncr. 21945.
4. Teng J, Wang ZY, Jarrard DF, Bjorling DE (2008) Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr Relat Cancer 15(1): 351-364. doi: 10. 1677/erc. 1. 01255.
5. Sonpavde G, Okuno N, Weiss H, Yu J, Shen SS, Younes M, Jian W, Lerner SP, Smith CL (2007) Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology 69(6): 1221-1226. doi: 10. 1016/j. urology. 2007. 02. 041.
6. Kontos S, Kominea A, Melachrinou M, Balampani E, Sotiropoulou-Bonikou G (2010) Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis. Int J Urol 17(9): 801-809. doi: 10. 1111/j. 1442-2042. 2010. 02603. x.
7. Bindels EM, Vermey M, van den Beemd R, Dinjens WN, van Der Kwast TH (2000) E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Cancer Res 60(1): 177-183.
8. Mialhe A, Levacher G, Champelovier P, Martel V, Serres M, Knudsen K, Seigneurin D (2000) Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. J Urol 164(3 Pt 1): 826-835.
9. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H (2006) N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 12(9): 2780-2787. doi: 10. 1158/1078-0432. ccr-05-2387.
10. Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5): 871-890. doi: 10. 1016/j. cell. 2009. 11. 007.
11. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119(6): 1429-1437. doi: 10. 1172/JCI36183.
12. Muramaki M, Miyake H, Terakawa T, Kumano M, Sakai I, Fujisawa M (2010) Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection. Urol Oncol doi: 10. 1016/j. urolonc. 2010. 01. 005.
13. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM (2010) ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17(4): 319-332. doi: 10. 1016/j. ccr. 2010. 02. 030.
14. Goulioumis AK, Fuxe J, Varakis J, Repanti M, Goumas P, Papadaki H (2009) Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers. Oncol Rep 22(5): 1063-1068.
15. Zannoni GF, Prisco MG, Vellone VG, De Stefano I, Scambia G, Gallo D (2011) Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma. Histopathology 58(2): 265-275. doi: 10. 1111/j. 1365-2559. 2011. 03744. x.
16. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) World Health Organization/international society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. bladder consensus conference committee. Am J Surg Pathol 22(12): 1435-1448.
17. Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP (2001) E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57(1): 60-65.
18. Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC (2007) Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13(6): 1685-1694. doi: 10. 1158/1078-0432. ccr-06-2330.
19. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4): 457-463. doi: 10. 1007/s00345-011-0709-9.
20. Kontos S, Papatsoris A, Kominea A, Melachrinou M, Tanoglidi A, Kachrilas S, Karavitakis M, Balampani E, Sotiropoulou-Bonikou G (2011) Expression of ERbeta and its co-regulators p300 and NCoR in human transitional cell bladder cancer. Urol Int 87(2): 151-158. doi: 10. 1159/000324262.
21. Bryan RT, Tselepis C (2010) Cadherin switching and bladder cancer. J Urol 184(2): 423-431. doi: 10. 1016/j. juro. 2010. 04. 016.